EBCC-9 | 9th European Breast Cancer | Neoadjuvant Therapy

In this video, developed in association with the European Breast Cancer ConferenceBreast Cancer TV and Quadia Online Video and sponsored by an educational grant from Novartis Oncology:

  • Nathalie Quenel-Tueux, MD, Medical Oncologist at the Cancer Institut Bergoni?, Bordeaux, France, discusses neoadjuvant endocrine therapy with fulvestrant and anastrozol (Tomorrow?s practice changing presentation);
  • Sibylle Loibl, MD, Professor at the University of Frankfurt, Frankfurt, Germany, and a member of the German Breast Group (GBG), discusses neoadjuvant chemotherapy in lobular carcinoma (Today?s practice changing presentation).

Copyright ? 2014 InPress Media Group/Sunvalley Communication. All rights reserved. Republication or redistribution of InPress Media Group/Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group/Sunvalley Communication. InPress Media Group/Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco’Zine and Oncozine are registered trademarks and trademarks of Sunvalley Communication around the world.